
Synthetic biologist/Assistant Professor @HKUST;Postdoc in RLE in the Lu lab @MIT;PhD in Microbiology @HKUniversity
Clear Water Bay, Hong Kong SAR
Joined April 2013
- Tweets261
- Following405
- Followers149
- Likes400
Yong Lai retweeted
One of the most amazing things I’ve ever seen: a standing ovation for the full Daraxonrasib results
I feel inspired and energised, to put it mildly — we have a targeted therapy for pancreatic cancer now, and nothing is undruggable anymore
Yong Lai retweeted
Dr. Kanya Rajangam, Chief Medical Officer, emphasized that the encouraging SENTI-202 data support advancement into pivotal studies and exploration across additional patient populations, enabled by recent RMAT and Orphan Drug Designations.
bit.ly/3XFf7ST
$SNTI #ASH2025
Yong Lai retweeted
1/ Excited to share our new paper in Science: “Toward life with a 19-amino acid alphabet through generative artificial intelligence design.” @ColumbiaSysBio @ColumbiaBME @Columbia
science.org/doi/10.1126/scie… 🦠🧬🛠️🖥️💥
For the first time, researchers have simulated nearly every chemical reaction in a living bacterial cell
go.nature.com/46UnkYp
Yong Lai retweeted
🚀 Introducing Dream-VL & Dream-VLA!
We’re proving that dLLMs have an amazing advantage in building VLA models.
The result is stunning performance:
🏆 97.2% on LIBERO
⚡ 27x speedup vs AR models
🔥 Beats OpenVLA & $\pi_0$
✅ Fully Open Source
Blog: hkunlp.github.io/blog/2025/d…
Yong Lai retweeted
The world has lost one of the greatest physicists of the 20th century.
"Nature seems to take advantage of the simple mathematical representations of the symmetry laws"
Chen-Ning Yang (1922–2025)
✨New preprint alert✨Ever tried baking sourdough at home? 🍞Fascinated by the magic of fermentation and the tiny microbes behind it? What if we could give them intelligence, logic, and teamwork across kingdom to treat complex gut disease? That’s the vision behind our SINERGY!
Sourdough starter-inspired living materials grown from probiotic consortia with engineered division-of-labor biorxiv.org/content/10.1101/… #biorxiv_synbio
Proud to share our lab’s first research paper, led by my incredible PhD student Shuchen Wang! 🎉 Huge thanks to our amazing collaborators for making this possible!! @ZijayTang
Just noticed this. It’s so interesting! 😄
“I’ve been baking” | #TaylorSwift talks about her obsession with sourdough
📺 watch the full chat here youtu.be/lz6sTxdnzZk
We’re grateful to IAI journal and ASM for the invitation. We summarized a range of CRISPR-based tools for studying host-microbe interactions. The article will be published soon!🥳
Know a rising star who studies host-microbe interactions? Nominate an exceptional early-career scientist to author a minireview in #IAIJournal’s 2026 New Voices in Microbiology Collection. Submit your nomination by Aug. 18: asm.social/2vO
Yong Lai retweeted
Product update: Indel Analysis lets you score insertions/deletions across your sequence using PoET-2. You can now also compare multiple 3D structures in Mol* to evaluate design alternatives.
Sign up now: openprotein.ai/early-access-…
Yong Lai retweeted
My dept in London at Imperial (Bioengineering) is recruiting a group leader at Professor level 🧑🎓 Please RT. It's a great department with world-class expertise in all sorts of biomedical & biological engineering topics, including synthetic biology. 🇬🇧imperial.ac.uk/jobs/search-j…
Yong Lai retweeted
Super excited about the release of our open diffusion language model! Dream 7B has finally achieved the general language model capabilities I've been dreaming of since we started working on discrete diffusion models. Check out our blog post for details: hkunlp.github.io/blog/2025/d…
Yong Lai retweeted
Excited to share the latest clinical and preclinical data on our Logic Gated SENTI-202 product at the upcoming AACR meeting!
Kanya Rajangam, MD, PhD, President and Chief Medical Officer of $SNTI, shares her excitement for the upcoming data presentation from the SENTI-202 trial at the AACR Annual Meeting being held April 25-30, 2025
bit.ly/3QYtOx5
@AACR
Yong Lai retweeted
Excited to share PoET-2, our next breakthrough in protein language modeling. It represents a fundamental shift in how AI learns from evolutionary sequences. 🧵 1/13
Yong Lai retweeted
Engineered cells are finding their way into agriculture, living materials, consumer products and medicines. How do we design these cells and adapt regulatory rules to facilitate their safe and efficient use? #synbio #biotech rdcu.be/d8xLG
Yong Lai retweeted
Apply now, spread the word: three (3) fully funded Helmholtz research groups (assistant prof level) with attractive packages. Topics: RNA-based medicine, microbial RNA, and RNA-based infection research incl. RNA technologies. Great environment for young people. Come and join us.
Yong Lai retweeted
Very excited to share details on SENTI-202 clinical trial - 2 of 3 pts achieved MRD negative CR in 1st dose level evaluated with a generally well-tolerated preliminary safety profile. Both patients continue to maintain remission (4+ and 3+ months, respectively). $SNTI
Today, we announced positive initial clinical data from the Phase 1 trial of SENTI-202, a potential first-in-class, off-the-shelf #CARNK #celltherapy for R/R hematologic malignancies, including #AML. Learn more on our webcast on Dec. 3 at 7:30am ET: bit.ly/4eUaKtb $SNTI
Yong Lai retweeted
Today, we announced positive initial clinical data from the Phase 1 trial of SENTI-202, a potential first-in-class, off-the-shelf #CARNK #celltherapy for R/R hematologic malignancies, including #AML. Learn more on our webcast on Dec. 3 at 7:30am ET: bit.ly/4eUaKtb $SNTI


























